Edwards Lifesciences Corp
Change company Symbol lookup
Select an option...
EW Edwards Lifesciences Corp
COP ConocoPhillips
FBP First Bancorp
PTCT PTC Therapeutics Inc
ROKU Roku Inc
WORK Slack Technologies Inc
ARKW ARK Next Generation Internet ETF
SPOT Spotify Technology SA
GBTC Grayscale Bitcoin Trust (BTC)
ARKK ARK Innovation ETF
Go

Health Care : Health Care Equipment & Supplies | Large Cap Growth
Company profile

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products are categorized into three areas: Transcatheter Heart Valve Therapy, Surgical Heart Valve Therapy and Critical Care. It also develops hemodynamic monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. It is developing products, such as the Edwards SAPIEN 3 Ultra System and Edwards SAPIEN XT transcatheter heart valve, among others. Its Transcatheter Heart Valve Therapy and Surgical Heart Valve Therapy products are manufactured in the United States, Singapore and Switzerland. Critical Care products are manufactured in its facilities located in Puerto Rico and the Dominican Republic.

Closing Price
$87.87
Day's Change
0.38 (0.43%)
Bid
--
Ask
--
B/A Size
--
Day's High
88.15
Day's Low
86.84
Volume
(Heavy Day)
Volume:
3,128,902

10-day average volume:
2,258,643
3,128,902

Portnoy Law Firm: Las Vegas Sands, Corp., Raytheon Technologies Corporation, and Royal Caribbean Cruises, Ltd. Investors Have Limited Amount of Time Before Class Action Deadline

8:00 am ET November 27, 2020 (Globe Newswire) Print

Investors with losses are encouraged to contact Attorney Lesley F. Portnoy.

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Las Vegas Sands, Corp. investors (NYSE: LVS); December 21, 2020 deadline, click here to join.

Raytheon Technologies Corporation investors (NYSE: RTX); December 29, 2020 deadline, click here to join.

Royal Caribbean Cruises, Ltd. investors (NYSE: RCL); December 7, 2020 click here to join.

Las Vegas Sands, Corp. The allegations of fraud focus on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Bloomberg reported on September 16, 2020, that Las Vegas Sands' Singapore casino, Marina Bay Sands, "has hired a law firm to conduct a new investigation into employee transfers of more than $1 billion in gamblers' money to third parties[.]" Singapore's Casino Regulatory Authority stated "there were weaknesses in [Marina Bay Sands'] casino control measures pertaining to fund transfers[.]" Based on this news, shares of Las Vegas Sands fell by 4.2% on the same day.

Raytheon Technologies Corporation According to the lawsuit, throughout the Class Period the defendants made misleading and/or false statements and/or failed to disclose that: (1) Raytheon had inadequate procedures and disclosure controls and internal control over financial reporting; (2) Raytheon's financial accounting was faulty; (3) Raytheon misreported its costs regarding Raytheon's Missiles & Defense business since 2009 as a result; (4) Raytheon was at risk of increased scrutiny from the government as a result of the foregoing; (5) Raytheon would face a criminal investigation by the U.S. Department of Justice ("DOJ") as a result of the foregoing; and (6) Raytheon's public statements were materially misleading and/or false at all relevant times, as a result. The lawsuit claims that investors suffered damages when the true details entered the market.

Royal Caribbean Cruises, Ltd. It is alleged in the complaint that Royal Caribbean throughout the Class Period made materially misleading and/or false statements and/or failed to disclose material adverse facts about a decrease in its bookings outside China, as well as its faulty procedures and policies to prevent the circulation of COVID-19 on its cruise ships. Specifically, in regard to global bookings, Royal Caribbean: (1) misled investors to believe that any issues related to COVID-19 were relatively insignificant; (2) falsely assured investors that bookings outside China were strong and showed no signs of a slowdown; and (3) failed to disclose that material declines in bookings globally due to customer concerns over COVID-19 were being experienced by Royal Caribbean. Additionally, in regard to safety procedures, Royal Caribbean: (1) falsely assured investors that rigorous safety protocols were implemented; (2) stated such protocols were ultimately expected to contain the spread of COVID-19; and (3) failed to disclose that its ships were following protocols that were grossly inadequate and that would foster the spread of COVID-19, posing a substantial risk to crews and passengers. The lawsuit claims that investors suffered damages, when the true details entered the market.

The Portnoy Law Firm represents investors on a contingency basis in pursuing claims caused by corporate wrongdoing. The Firm's founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.

Admitted CA and NY Bar

lesley@portnoylaw.com

310-692-8883

www.portnoylaw.com

Attorney Advertising

https://ml.globenewswire.com/media/ea0dd9c0-6e41-4d5a-ad27-b277677af6df/small/portnoylaw-logohighresroundlogoonly-jpg.jpg

https://ml.globenewswire.com/media/ea0dd9c0-6e41-4d5a-ad27-b277677af6df/small/portnoylaw-logohighresroundlogoonly-jpg.jpg

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.